Literature DB >> 10989255

Evidence-based review of the literature on intrathecal delivery of pain medication.

G Bennett1, M Serafini, K Burchiel, E Buchser, A Classen, T Deer, S Du Pen, F M Ferrante, S J Hassenbusch, L Lou, J Maeyaert, R Penn, R K Portenoy, R Rauck, K D Willis, T Yaksh.   

Abstract

Evidence-based medicine depends on the existence of controlled clinical trials that establish the safety and efficacy of specific therapeutic techniques. Many interventions in clinical practice have achieved widespread acceptance despite little evidence to support them in the scientific literature; the critical appraisal of these interventions based on accumulating experience is a goal of medicine. To clarify the current state of knowledge concerning the use of various drugs for intraspinal infusion in pain management, an expert panel conducted a thorough review of the published literature. The exhaustive review included 5 different groups of compounds, with morphine and bupivacaine yielding the most citations in the literature. The need for additional large published controlled studies was highlighted by this review, especially for promising agents that have been shown to be safe and efficacious in recent clinical studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989255     DOI: 10.1016/s0885-3924(00)00204-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  18 in total

1.  Intrathecal catheter tip inflammatory mass lesions (granulomas): a case report with bone destruction and review of imaging findings.

Authors:  Beril Gok; Mohammadreza Hayeri; Richard Kanoff; Michael Brooks
Journal:  Emerg Radiol       Date:  2012-07-06

2.  Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pharmacol Biochem Behav       Date:  2011-09-17       Impact factor: 3.533

3.  Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity.

Authors:  S A Sadiq; C A Poopatana
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

4.  Effects of butorphanol on morphine-induced itch and analgesia in primates.

Authors:  Heeseung Lee; Norah N Naughton; James H Woods; Mei-Chuan Ko
Journal:  Anesthesiology       Date:  2007-09       Impact factor: 7.892

5.  Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Brain Res       Date:  2011-07-26       Impact factor: 3.252

6.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

Review 7.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management.

Authors:  Carrie J Aigner; Mike Hernandez; Lakshmi Koyyalagunta; Diane Novy
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

Review 9.  Management strategies for the treatment of neuropathic pain in the elderly.

Authors:  Mahmood Ahmad; Charles Roger Goucke
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.

Authors:  Hong Xie; James H Woods; John R Traynor; Mei-Chuan Ko
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.